Physicochemical cargo-switching nanoparticles (CSNP)
designed by KAIST can help significantly reduce cholesterol and
macrophage foam cells in arteries, which are the two main triggers
for atherosclerotic plaque and inflammation.
Physicochemical cargo-switching nanoparticles (CSNP)
designed by KAIST can help significantly reduce cholesterol and
macrophage foam cells in arteries, which are the two main triggers
for atherosclerotic plaque and inflammation.